Hainan People's Hospital
28
5
7
2
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 28 trials
100.0%
+13.5% vs industry average
18%
5 trials in Phase 3/4
0%
0 of 2 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (28)
Neoadjuvant Oral Paclitaxel Plus Subcutaneous Pertuzumab/Trastuzumab in Patients With HER2-positive Breast Cancer
Role: collaborator
Posterior Extra-fascial RARP in Intermediate or High Risk Prostate Cancer
Role: collaborator
PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma
Role: collaborator
Prospective Study on Monitoring Parotid Gland Injury After Radiotherapy for Head and Neck Tumors Using Multimodal Radiomics
Role: lead
Comparison of Multi-omics Models for Early Nasopharyngeal Carcinoma Screening: CfDNA Methylation, EBV DNA, and Serological Double-antibodies Detection
Role: collaborator
Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study
Role: collaborator
The Epidemiological and Intrinsic Characteristics of Chronic Rhinitis
Role: collaborator
Detection and Biopsy Guidance of Nasopharyngeal Carcinoma Based on Artificial Intelligence and Endoscopic Images
Role: collaborator
Precise Profiling of Liver Disease Patients With DPMAS Therapy, Treating Optimal Patients and Achieving Hard Endpoint (PADSTONE Study)
Role: collaborator
Association of Osmotic Drugs With Clinical Outcomes in Acute Large Hemispheric Infarction
Role: collaborator
Association of Prophylactic Use of Stress Ulcer Drugs and Clinical Outcomes in Patients With Acute Anterior Circulation Thrombectomy
Role: collaborator
SPT-07A Injection in Patients With Acute Ischemic Stroke (AIS): A Phase III Clinical Trial
Role: collaborator
South China Children Cancer Group - Relapsed-Acute Lymphoblastic Leukemia 2022 Protocol
Role: collaborator
Registry of Multimodality Treatment for Brain Arteriovenous Malformation in Mainland China
Role: collaborator
A Study to Evaluate TACE Sequential Tislelizumab as Adjuvant Therapy in Participants With HCC at High Risk of Recurrence After Curative Resection
Role: collaborator
Nutritional Management in Respiratory Critically Ill Patients -an Observational Study in Mainland China
Role: collaborator
Chinese Research Group of Gallbladder Cancer
Role: collaborator
A Single Center Registry of Coronary OCT
Role: lead
A Registry of De Winter Symdrome of Single Center
Role: lead
Effect of Chemoradiotherapy on Nutritional Status in Advanced NPC Patients
Role: collaborator